everolimus 5 MG Oral Tablet
- RxCUI
- 845515
- RxNorm name
- everolimus 5 MG Oral Tablet
- Display name
- everolimus 5 MG Oral Tablet
- Full name
- everolimus 5 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TORPENZ | EVEROLIMUS | Upsher-Smith Laboratories, LLC | 4c0075dd-a0a8-4dc4-be32-1be8383fbbdc | 2026-06-10 | Warnings, Adverse reactions | 845515 |
| Afinitor | EVEROLIMUS | Novartis Pharmaceuticals Corporation | 2150f73a-179b-4afc-b8ce-67c85cc72f04 | 2026-06-01 | Warnings, Adverse reactions | 845515 |
| Yulithira | EVEROLIMUS | CivicaScript, LLC | 5e325efa-8ae6-4dac-b59b-d7c74c73186c | 2026-03-31 | Warnings, Adverse reactions | 845515 |
| everolimus | EVEROLIMUS | Novugen Pharma (USA) LLC. | 67e62e26-448d-46ec-b5a1-00dc1b5e26c6 | 2026-03-10 | Warnings, Adverse reactions | 845515 |
| Everolimus | EVEROLIMUS | Breckenridge Pharmaceutical, Inc. | 01f7b5fb-be0d-4adf-acd2-6899018de966 | 2025-09-05 | Warnings, Adverse reactions | 845515 |
| EVEROLIMUS | EVEROLIMUS | Biocon Pharma Inc. | 5fb55800-f322-6bb6-9dde-622925ef28bd | 2025-03-21 | Warnings, Adverse reactions | 845515 |
| EVEROLIMUS | EVEROLIMUS | NorthStar RxLLC | 5cfca904-b75c-5a39-8cb9-b99bb421bceb | 2024-08-02 | Warnings, Adverse reactions | 845515 |
| Everolimus | EVEROLIMUS | Hikma Pharmaceuticals USA Inc. | 5aaf2fb7-93f6-40d6-941a-9583a3794ce7 | 2024-04-23 | Warnings, Adverse reactions | 845515 |
| Everolimus | EVEROLIMUS | Natco Pharma Limited | e3dbbc24-7e55-4069-a305-e2cded2db641 | 2023-06-08 | Warnings, Adverse reactions | 845515 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2150f73a-179b-4afc-b8ce-67c85cc72f04 | everolimus 5 MG Oral Tablet | PSN | 66 | These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 2009 | 20260212 |
| 2150f73a-179b-4afc-b8ce-67c85cc72f04 | everolimus 5 MG Oral Tablet | SCD | 66 | These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 2009 | 20260212 |
| 45d54974-3fc4-4237-a2fa-3158ca1a8105 | everolimus 5 MG Oral Tablet | PSN | 23 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20260116 |
| 45d54974-3fc4-4237-a2fa-3158ca1a8105 | everolimus 5 MG Oral Tablet | SCD | 23 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20260116 |
| 01f7b5fb-be0d-4adf-acd2-6899018de966 | everolimus 5 MG Oral Tablet | PSN | 20 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 2009 | 20250905 |
| 01f7b5fb-be0d-4adf-acd2-6899018de966 | everolimus 5 MG Oral Tablet | SCD | 20 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 2009 | 20250905 |
| 4c0075dd-a0a8-4dc4-be32-1be8383fbbdc | everolimus 5 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use TORPENZ TABLETS safely and effectively. See full prescribing information for TORPENZ TABLETS. TORPENZ™ (everolimus) tablets, for oral use Initial U.S. Approval: 2009 | 20260215 |
| 4c0075dd-a0a8-4dc4-be32-1be8383fbbdc | everolimus 5 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use TORPENZ TABLETS safely and effectively. See full prescribing information for TORPENZ TABLETS. TORPENZ™ (everolimus) tablets, for oral use Initial U.S. Approval: 2009 | 20260215 |
| 5fb55800-f322-6bb6-9dde-622925ef28bd | everolimus 5 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20250321 |
| 5fb55800-f322-6bb6-9dde-622925ef28bd | everolimus 5 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20250321 |
| e3bca36b-29ed-4a2b-a1be-a57b6af805f6 | everolimus 5 MG Oral Tablet | PSN | 10 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS . EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20260309 |
| e3bca36b-29ed-4a2b-a1be-a57b6af805f6 | everolimus 5 MG Oral Tablet | SCD | 10 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS . EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20260309 |
| 5aaf2fb7-93f6-40d6-941a-9583a3794ce7 | everolimus 5 MG Oral Tablet | PSN | 9 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20240423 |
| 5aaf2fb7-93f6-40d6-941a-9583a3794ce7 | everolimus 5 MG Oral Tablet | SCD | 9 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20240423 |
| e3dbbc24-7e55-4069-a305-e2cded2db641 | everolimus 5 MG Oral Tablet | SCD | 7 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20230608 |
| e3dbbc24-7e55-4069-a305-e2cded2db641 | everolimus 5 MG Oral Tablet | PSN | 7 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20230608 |
| 5cfca904-b75c-5a39-8cb9-b99bb421bceb | everolimus 5 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use EVEROLIMUS safely and effectively. See full prescribing information for EVEROLIMUS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20240802 |
| 5cfca904-b75c-5a39-8cb9-b99bb421bceb | everolimus 5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use EVEROLIMUS safely and effectively. See full prescribing information for EVEROLIMUS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20240802 |
| 67e62e26-448d-46ec-b5a1-00dc1b5e26c6 | everolimus 5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20260310 |
| 67e62e26-448d-46ec-b5a1-00dc1b5e26c6 | everolimus 5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use EVEROLIMUS TABLETS safely and effectively. See full prescribing information for EVEROLIMUS TABLETS. EVEROLIMUS tablets, for oral use Initial U.S. Approval: 2009 | 20260310 |